Table 3.

DVH metrics of prostate and DIL in different plans among all 17 patients.

	Prostate-DIL a				DIL
	D90(%)	V100(%)	V150(%)	V200(%)	D90(%)	V100(%)	V150(%)	V175(%)	V200(%)
I b	106.6 ± 1.7	94.7 ± 1.2	35.9 ± 3.7	14.0 ± 1.7	114.6 ± 21.9	94.4 ± 9.7	46.4 ± 28.6	26.3 ± 21.4	19.1 ± 16.6
II	105.5 ± 2.6	93.7 ± 1.7	37.1 ± 4.0	15.1 ± 1.9	151.6 ± 22.8	98.7 ± 4.8	87.0 ± 15.5	69.3 ± 20.9	52.9 ± 21.9
III	106.3 ± 3.1	93.9 ± 1.9	37.1 ± 4.0	14.6 ± 2.1	164.5 ± 21.1	99.4 ± 2.5	93.0 ± 14.1	79.5 ± 18.6	65.2 ± 16.8
P-values
I vs II	0.149	0.049	0.163	0.015	<0.001	<0.001	<0.001	<0.001	<0.001
I vs III	0.979	0.326	0.215	0.070	<0.001	<0.001	<0.001	<0.001	<0.001
II vs III	0.393	0.836	0.717	0.179	0.001	0.250	<0.001	0.002	0.020

^aProstate - DIL = Prostate with DIL cropped.

^bI, II and III are “Original”, “Original Boost” and “Additional Boost” plans, respectively.